Seres Therapeutics

About Seres Therapeutics

Seres Therapeutics is dedicated to transforming the lives of patients worldwide by developing revolutionary live biotherapeutics. Their mission focuses on creating new treatments for medically vulnerable populations to prevent bacterial bloodstream and antimicrobial resistant (AMR) infections, as well as to treat GI-related immune diseases.

Products & Services

VOWST™:A biotherapeutic product involved in an asset sale agreement with Nestlé Health Science.

Live Biotherapeutics:Innovative treatments targeting bacterial bloodstream infections, antimicrobial resistant infections, and GI-related immune diseases.

Specialties

Live Biotherapeutics Microbiome Health Prevention of Bacterial Infections Treatment of GI-related Immune Diseases Antimicrobial Resistance (AMR)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 3600000 MR: - FA: up to $3.6 million FAN: 3600000	D: 2025-10-29 FD: 2025-10-29	1 investors
2	RT: Debt T: - FT: Debt	A: 250000000 MR: - FA: $250 million FAN: 250000000	D: 2023-04-27 FD: 2023-04-27	1 investors

Grant Latest

2025-10-29

$3.6M

1 investor (Pro only)

Debt 2023-04-27

$250.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Keith H.

Senior Manager, Pharmacology

S

Shelby E.

Senior Associate in Analytical Development

V

Varun M.

Senior Scientist, Computational Biology

T

Thomas J. DesRosier

Co-President/Chief Executive Officer, Chief Legal Officer and Secretary

M

Marella Thorell

Co-President/Chief Executive Officer, Chief Financial Officer

M

Matthew Henn

EVP, Chief Scientific Officer

View 23 more team members with Pro

Unlock Full Team Directory

Recent News